ABLX - Ablynx NV

. Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Sanofi Focuses on Integrating Recently Acquired Ablynx
    Market Realist11 months ago

    Sanofi Focuses on Integrating Recently Acquired Ablynx

    On January 29, Sanofi announced its acquisition of Ablynx for $4.8 billion, and it announced the completion of the acquisition on June 19. The acquisition was one of two announced in January to advance its blood disorder portfolio. The other acquisition was of Bioverative.

  • What does Ablynx NV’s (EBR:ABLX) Balance Sheet Tell Us About Its Future?
    Simply Wall St.last year

    What does Ablynx NV’s (EBR:ABLX) Balance Sheet Tell Us About Its Future?

    Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as Ablynx NV (EBR:ABLX), with a market cap of €3.38b, often get neglectedRead More...

  • Ablynx NV (EBR:ABLX): What Does The Future Look Like?
    Simply Wall St.last year

    Ablynx NV (EBR:ABLX): What Does The Future Look Like?

    The most recent earnings release Ablynx NV’s (ENXTBR:ABLX) announced in December 2017 suggested that losses became smaller relative to the prrior year’s level – great news for investors Below, I’veRead More...